Publicaciones (10) Publicaciones en las que ha participado algún/a investigador/a

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Author Correction: Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries (Nature Genetics, (2023), 55, 1, (89-99), 10.1038/s41588-022-01222-9)

    Nature Genetics

  3. Correction to: Stabilization of Hypoxia-Inducible Factors and BNIP3 Promoter Methylation Contribute to Acquired Sorafenib Resistance in Human Hepatocarcinoma Cells (Cancers, (2019), 11, 12, (1984), 10.3390/cancers11121984)

    Cancers

  4. Corrigendum to “An optimized centrifugation protocol for ram sperm ensuring high sample yield, quality and fertility” [Theriogenology 191 (2022) 179–191, (S0093691X2200293X), (10.1016/j.theriogenology.2022.08.006)]

    Theriogenology

  5. Corrigendum to “Dissecting the genetic heterogeneity of gastric cancer” (eBioMedicine (2023) 92, (S2352396423001810), (10.1016/j.ebiom.2023.104616))

    eBioMedicine

  6. Corrigendum: Role of NAFLD on the health related QoL response to lifestyle in patients with metabolic syndrome: The PREDIMED plus cohort(Front. Endocrinol., (2022), 13, (868795), 10.3389/fendo.2022.868795)

    Frontiers in Endocrinology

  7. Creation of a Pediatric Hospital Medicine Subspecialty in Spain

    Hospital Pediatrics

  8. Erratum: A comparison of the effects of kaempferol and quercetin on cytokine-induced pro-inflammatory status of cultured human endothelial cells (British Journal of Nutrition (2008) 100: 5 (968-976) DOI: 10.1017/S0007114508966083)

    British Journal of Nutrition

  9. Population health surveys and screening tools for depressive disorders: Aims and uses

    BMJ Mental Health

  10. Therapeutic approaches in intermediate-stage hepatocellular carcinoma (HCC): a novel insight of adjuvant transarterial chemoembolization (TACE)

    Chinese Clinical Oncology